century-old debate protein aggregation neurodegeneration enters clinic
correlation neurodegenerative disease protein aggregation brain long recognized causal relationship unequivocally established part discrete pathogenic aggregate identified complexity diseases dynamic nature protein aggregation mean despite progress towards understanding aggregation relationship disease difficult determine laboratory nevertheless drug candidates inhibit aggregation now tested clinic potential slow progression alzheimers disease parkinsons disease related disorders administered presymptomatically drastically reduce incidence diseases clinical trials also settle century-old debate causality
